Navigation Links
Oncolytics Biotech Inc. Announces Positive Clinical Data from U.S.,Phase I REOLYSIN Trial

(MTD), dose limiting toxicity (DLT), and safety profile of REOLYSIN(R) when administered systemically to patients. A secondary objective is to examine any evidence of anti-tumour activity. Eligible patients included those who had been diagnosed with advanced or metastatic solid tumours that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the results of the Phase I US Systemic Administration clinical trial investigating delivery of REOLYSIN(R) for advanced cancers, and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, actual patient tolerance, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory
'"/>




Page: 1 2 3

Related medicine technology :

1. Oncolytics Biotech Inc.s Research Collaborators to Present REOLYSIN Clinical Trial Data at ASCO Conference
2. Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines
3. Oncolytics Biotech Inc. Collaborators to Present Reovirus/Gemcitabine Combination Research at AACR Annual Meeting
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
8. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
9. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
10. New Positive Pre-clinical Data for Active Biotechs RA Project I-3D
11. Prana Biotechnology Presents New Key Findings on PBT2
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... Aug. 29, 2014 Diseases largely eradicated in ... ago are returning. Measles was declared eliminated in 2000, ... as of August 15—the highest incidence in 20 years. ... department declared whooping cough a problem of "epidemic ... sick and dying from these preventable diseases—in part because ...
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... ,, THE WOODLANDS, Texas , June 1 ... oncology company, today announced its new iKnowMed™ Technology Platform to ... quality and practice efficiency through integrated, oncology-specific technologies that enable ... delivery, drug management, and revenue cycle management.   , ...
... June 1 Upsher-Smith Laboratories, Inc. announces the availability ... to the amounts of folic acid and iron.   , ... According to the American ... folic acid during pregnancy.(1)  PreNexa®,s newest formulation contains 1.25 mg of ...
Cached Medicine Technology:US Oncology Announces iKnowMed(TM) Technology Platform 2US Oncology Announces iKnowMed(TM) Technology Platform 3US Oncology Announces iKnowMed(TM) Technology Platform 4US Oncology Announces iKnowMed(TM) Technology Platform 5US Oncology Announces iKnowMed(TM) Technology Platform 6US Oncology Announces iKnowMed(TM) Technology Platform 7US Oncology Announces iKnowMed(TM) Technology Platform 8Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins 2Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins 3
(Date:9/1/2014)... MN (PRWEB) September 01, 2014 In honor of ... on Aug. 22, Animal Emergency & Referral Center of Minnesota (AERC) ... visits a priority for their cats. , Many people don’t take ... too much of a hassle,” but they wouldn’t decide not to ... signs of a cavity. The same goes for pets. Just like ...
(Date:9/1/2014)... Vegas, NV (PRWEB) September 01, 2014 ... entrepreneurs and online marketers that was developed to automate ... has caught the attention of Shane Michaels, prompting an ... established entrepreneur, the daily duty of managing all of ... business can be quite overwhelming,” reports Michaels. “That’s why ...
(Date:9/1/2014)... Pastor Thompson is an ordained minister and previously worked as ... licensed minister through the Church of the Nazarene and has ... Mexico, Colorado and North Dakota. He and his wife Heather ... also has two beautiful daughters, Brianna, 22 and Bethany, 17. ... Bible College, in Colorado Springs and is currently pursuing his ...
(Date:9/1/2014)... New York, US (PRWEB) September 01, 2014 ... a top-line view into Heartbeat Experts’ perspectives ... the Diabetes market. , Download the flash ... stakeholder strategies for any launching Diabetes product:, ... of differentiation within an increasingly crowded market ...
(Date:8/31/2014)... August 31, 2014 The FDA has ... Facts label. If adopted, the proposed changes would include ... of “added sugars” on the label, and a new ... keep “added sugars” off the label. NutriGold fully supports ... make healthier food choices. “After 20 years, it's time ...
Breaking Medicine News(10 mins):Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Diabetes Products 2Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 2Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 3Health News:NutriGold Supports the FDA's Call for an Updated Nutrition Facts Label 4
... , , New line set to hit market in ... -- Jillian Michaels, New York Times bestselling author ... Loser announces her first ever line of weight-loss products in ... at the 2009 National Association of Chain Drug Stores Marketplace in ...
... ... psoriasis medications and the financial help available for those living with the disease ... (Vocus) June 29, 2009 -- ... those with psoriasis . The page is a psoriasis-specific source of help for those ...
... Florida,s First Certified Urgent Care ... Florida has become the first in the State to receive formal recognition as a Certified Urgent ... ... Medical Centers of Palm Beach County Florida has become the first in the State to receive ...
... , ... founder of the alternative health movement, is now a featured expert on searchvitaminsupplements.com, a new ... acids, enzymes, and more. , ... Potomac, MD (Vocus) June 29, 2009 -- Julian Whitaker, MD , a founder of ...
... ... the US Drug Watchdog, "we want to hear from any Zicam Nasal ... smell." The group says, "on June 16, 2009, the U.S. Food and ... remedies because they are associated with the loss of sense of smell ...
... 29 /PRNewswire-Asia/ -- Rising healthcare standards,together with the growing ... for medical tourism buoyant, according to experts speaking at ... Singapore.,Worldwide gross medical tourism revenue is projected to grow ... Asia as a major driver of this,growth. , ...
Cached Medicine News:Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 2Health News:Jillian Michaels, 'America's Toughest Trainer,' Announces New Line of Weight-Loss Supplements 3Health News:New Source of Information on Psoriasis Medications 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 2Health News:MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care 3Health News:Dr. Julian Whitaker Featured on Searchvitaminsupplements.com 2Health News:The US Drug Watchdog Expands its Zicam Investigation and Wants to Hear From All Users Who Lost Their Sense of Smell 2Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 2Health News:Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012 3
The GE e-Speed™scanner, the worlds fastest computed tomography (CT) imaging platform, delivers a new advanced tool for physicians to see and diagnose heart disease....
...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
16mm Slightly Curved sharp Tips; overall length 120mm; Stainless Steel...
Medicine Products: